HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mami Takahashi Selected Research

nitrosobis(2-oxopropyl)amine (NBOP)

5/2021Effect of Fucoxanthinol on Pancreatic Ductal Adenocarcinoma Cells from an N-Nitrosobis(2-oxopropyl)amine-initiated Syrian Golden Hamster Pancreatic Carcinogenesis Model.
10/2018Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans.
3/2013Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents.
2/2011Experimental animal models of pancreatic carcinogenesis for prevention studies and their relevance to human disease.
10/2007Enhanced thyroid carcinogenicity of N-nitrosobis(2-oxopropyl)amine in Otsuka Long-Evans Tokushima Fatty rats, a model of type II diabetes mellitus.
8/2007Suppression of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters by pioglitazone, a ligand of peroxisome proliferator-activated receptor gamma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mami Takahashi Research Topics

Disease

44Neoplasms (Cancer)
01/2022 - 01/2002
38Carcinogenesis
12/2021 - 01/2002
19Colonic Neoplasms (Colon Cancer)
03/2015 - 01/2002
17Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 08/2007
14Adenocarcinoma
05/2021 - 06/2004
10Intestinal Polyps
11/2015 - 09/2003
8Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 03/2006
8Aberrant Crypt Foci
11/2015 - 01/2002
8Hyperlipidemias (Hyperlipidemia)
03/2013 - 09/2003
7Polyps
11/2015 - 09/2003
6Inflammation (Inflammations)
01/2012 - 06/2004
4Body Weight (Weight, Body)
05/2018 - 10/2006
4Carcinoma (Carcinomatosis)
05/2013 - 05/2005
3Obesity
01/2016 - 08/2011
3Adenoma (Adenomas)
11/2012 - 06/2004
2Gastritis
08/2021 - 10/2003
2Infections
06/2019 - 09/2006
2Hypertriglyceridemia
01/2016 - 04/2008
2Type 2 Diabetes Mellitus (MODY)
07/2013 - 10/2007
2Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
04/2008 - 09/2003
1Peptic Esophagitis (Reflux Esophagitis)
01/2022
1Stomach Neoplasms (Stomach Cancer)
08/2021
1Atrophy
08/2021
1Chronic Pancreatitis
10/2020
1Endodermal Sinus Tumor (Endodermal Sinus Tumors)
04/2020
1Intracranial Arterial Diseases
01/2020
1Sarcoma (Soft Tissue Sarcoma)
11/2019
1Chondrosarcoma
04/2019
1Osteosarcoma (Osteogenic Sarcoma)
08/2018

Drug/Important Bio-Agent (IBA)

12AzoxymethaneIBA
11/2015 - 01/2002
11Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2015 - 03/2002
10Proteins (Proteins, Gene)FDA Link
12/2021 - 06/2004
10Messenger RNA (mRNA)IBA
11/2015 - 01/2002
9Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2015 - 01/2002
7LigandsIBA
12/2021 - 09/2003
6nitrosobis(2-oxopropyl)amine (NBOP)IBA
05/2021 - 08/2007
6AdipokinesIBA
10/2018 - 04/2008
6EnzymesIBA
11/2015 - 06/2004
6ProstaglandinsIBA
03/2014 - 01/2002
6Triglycerides (Triacylglycerol)IBA
01/2012 - 09/2003
5PPAR gammaIBA
01/2012 - 09/2003
5LipidsIBA
11/2011 - 02/2005
4Pharmaceutical PreparationsIBA
06/2021 - 06/2018
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2012 - 09/2003
4Pioglitazone (Actos)FDA Link
01/2012 - 09/2003
4Prostaglandin E Receptors (Prostaglandin E Receptor)IBA
01/2006 - 01/2002
4Prostaglandins EIBA
12/2005 - 01/2002
3Carotenoids (Carotene)IBA
01/2022 - 05/2021
3fucoxanthinIBA
01/2022 - 03/2021
3fucoxanthinolIBA
01/2022 - 03/2021
3ORALIT (ORS)IBA
07/2016 - 01/2014
3CarcinogensIBA
03/2014 - 01/2002
3Lipoprotein Lipase (Diacylglycerol Lipase)IBA
01/2012 - 02/2005
37- chloro- 3- imino- 5- methyl- 2- azabicyclo(4.1.0)heptaneIBA
08/2008 - 03/2006
3sodium sulfate (sodium bisulfate)FDA LinkGeneric
08/2007 - 01/2005
3Dextrans (Dextran)FDA Link
08/2007 - 01/2005
3Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2006 - 10/2003
3beta CateninIBA
01/2006 - 06/2004
2Cisplatin (Platino)FDA LinkGeneric
04/2020 - 10/2017
2ProteomeIBA
08/2018 - 02/2018
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2017 - 01/2017
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2015 - 02/2008
2NADPH Oxidases (NAD(P)H oxidase)IBA
11/2015 - 03/2015
2sesamolIBA
03/2015 - 03/2014
2Plasminogen Activator Inhibitor 1IBA
01/2014 - 04/2008
2Leptin ReceptorsIBA
05/2013 - 08/2011
2Urethane (Ethyl Carbamate)IBA
11/2012 - 02/2008
2Indomethacin (Indometacin)FDA LinkGeneric
11/2012 - 01/2012
24- diethoxyphosphorylmethyl- N- (4- bromo- 2- cyanophenyl)benzamideIBA
01/2012 - 02/2005
2LeptinIBA
11/2011 - 08/2011
2Plasminogen Activators (Plasminogen Activator)IBA
06/2011 - 04/2008
2QuinoxalinesIBA
01/2010 - 02/2008
2HeptanesIBA
08/2008 - 03/2006
2Codon (Codons)IBA
02/2008 - 06/2004
2TeaIBA
04/2006 - 10/2003
2PPAR alphaIBA
02/2005 - 09/2003
1XanthophyllsIBA
01/2022
1Proton Pump InhibitorsIBA
01/2022
1Histamine H2 AntagonistsIBA
01/2022
1Chemokine CCL21IBA
12/2021
1CC ChemokinesIBA
12/2021
1Cadherins (E-Cadherin)IBA
12/2021
1Small Interfering RNA (siRNA)IBA
12/2021
1BariumIBA
08/2021
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
10/2020
1embelinIBA
10/2020
1E-SelectinIBA
10/2020
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
04/2020
1IfosfamideFDA LinkGeneric
04/2020
1Etoposide (VP 16)FDA LinkGeneric
04/2020
1GlypicansIBA
04/2020
1GemcitabineFDA Link
04/2020
1nilotinibFDA Link
01/2020
1Agrochemicals (Agricultural Chemicals)IBA
06/2019
1AminesIBA
05/2018

Therapy/Procedure

5Chemoprevention
12/2021 - 01/2006
4Therapeutics
04/2019 - 01/2012
2Transplantation
12/2021 - 08/2018
2Drug Therapy (Chemotherapy)
04/2020 - 01/2015
2Pancreaticoduodenectomy
10/2016 - 03/2014